Analysts’ Viewpoint on Market Scenario
Equine practitioners are practicing strict biosecurity at all farms, performance venues, racetracks, and the likes during the ongoing COVID-19 pandemic. It has been found that issues of recurring common horse healthcare problems are affecting market growth. Hence, stakeholders in the global market for equine healthcare should increase awareness about regular de-worming schedules and professional veterinary advice to reduce the incidence of recurring common horse healthcare problems. Therapeutics such as corticosteroids are being extensively used as joint injections. Bisphosphonates such as tiludronate disodium (Tildren) and clondronate (Osphos) are labelled for controlling clinical signs associated with navicular syndrome. There is a need for research surrounding bisphosphonate use in horses under the age of four.
Equine practitioners are performing a risk-benefit analysis to determine if a horse should receive a particular risk-based vaccine. This is necessary since extra vaccinations can be costly and can cause unnecessary stress to the horse. Manufacturers in the equine healthcare market are increasing the production of vaccines to improve clinical numbers. With the help of risk-benefit analysis, veterinarians are educating horse owners about different types of risk-based vaccines such as equine influenza and strangle vaccines for horses active at events.
Manufacturers in the equine healthcare industry are developing the anthrax vaccine for horses that live in an area where spores are known to thrive in the soil. On the other hand, pregnant mares during specific months of pregnancy are advised to receive certain risk-based vaccines. Companies are developing a diverse portfolio of vaccines such as the equine herpesvirus, botulism, and rotaviral diarrhea.
Apart from ensuring healthcare services for horses, the COVID-19 pandemic has drawn attention to the well-being of equine veterinarians. Stakeholders in the equine healthcare market are taking cues from the AVMA (American Veterinary Medical Association) such as following the hierarchy of controls to reduce the spread of novel infection among equine practitioners.
While PPE (personal protective equipment) serves an important protective function, the optimal way to prevent disease transmission is to use a combination of interventions from across the hierarchy of controls. Participants in the equine healthcare business are rescheduling non-urgent veterinary procedures. They are considering telemedicine as an alternative to in-person visits.
Common horse healthcare problems such as laminitis or thrush can leave a horse more likely to contract it again. Hence, participants in the market are educating horse owners to seek professional veterinary advice and veterinary intervention to improve clinical outcomes.
The high prevalence of allergies, colic, and mud fever, among other common horse healthcare problems, is triggering the demand for healthcare services. Such findings are contributing to the growth of the equine healthcare market. Problems of worms, sweet itch, and back problems are translating into revenue opportunities for market stakeholders.
Apart from drugs, vaccines, and supplemental feed additives, market stakeholders are boosting R&D in equestrian sports technology such as wearables for horses. As such, there is a need for validated approaches to consistently and regularly track healthcare parameters such as temperature, heart rate, and respiratory rates. Thus, wearable devices hold the promising potential to offer these statistics.
The data gathered by wearable devices have the ability to give an earlier indication of issues, which may require veterinary investigation. Such innovations are translating into incremental opportunities for med-tech companies in the equine healthcare market.
In the racing industry, medication use has changed drastically over the years, as manufacturers develop new drugs whilst scientists hone techniques they use to analyze and identify therapeutic medications. healthcare companies are focusing on maintaining a level playing field, protecting the safety of the horse, and protecting the betting public. As such, companies are boosting the production of corticosteroids, NSAIDs, and bisphosphonates, among other drugs.
Racing regulators have historically permitted NSAID use within 24-hrs of race time. However, in recent times, there have been recommendations to increase the timeframe to no earlier than 48-hrs.
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 698.7 Mn |
|
Market Forecast Value in 2028 |
US$ 972.8 Mn |
|
Growth Rate (CAGR) |
4.3% |
|
Forecast Period |
2021–2028 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross-segment analysis at the regional level. Moreover, the qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview. |
|
Format |
Electronic (PDF) |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global market for equine healthcare was worth US$ 698.7 Mn and is projected to reach a value of US$ 972.8 Mn by the end of 2028
The equine healthcare market is anticipated to grow at a CAGR of 4.3% during the forecast period
North America accounted for a major share of the global market for equine healthcare.
The key factors driving equine healthcare market expansion include increased trend of horseracing and noteworthy growth in spending toward activities pertaining to equine care across the major parts of the globe
Key players in the global equine healthcare industry include Sanofi (Merial), Zoetis, Vetoquinol S.A., Purina Animal Nutrition LLC., and Bayer AG
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Equine Healthcare Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Equine Healthcare Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Coagulation Disorders & Coagulation Pathways: Overview
5.2. Epidemiology: Coagulation Disorders
5.3. Regulatory Framework
5.4. Reimbursement Scenario
5.5. Equine Healthcare Market: Pricing Analysis
5.6. Equine Healthcare Market: Value Chain Analysis
5.7. Equine Healthcare Market: Porter’s Five Forces Analysis
6. Global Equine Healthcare Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Equine Healthcare Market Value Forecast, by Product Type, 2017–2028
6.2.1. Drugs
6.2.1.1. Anti-infectives
6.2.1.2. Anti-inflammatory
6.2.1.3. Parasiticides
6.2.1.4. Others
6.2.2. Vaccines
6.2.2.1. Inactivated
6.2.2.2. Live Attenuated
6.2.2.3. Recombinant
6.2.2.4. Others
6.2.3. Medical Supplemental Feed
6.2.3.1. Minerals
6.2.3.2. Vitamins
6.2.3.3. Protein
6.2.3.4. Enzyme
6.2.3.5. Others
6.3. Global Equine Healthcare Market Attractiveness Analysis, by Product Type
7. Global Equine Healthcare Market Analysis and Forecast, by Disease Type
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Equine Healthcare Market Value Forecast, by Disease Type, 2017–2028
7.2.1. West Nile Virus
7.2.2. Equine Rabies
7.2.3. Potomac Horse Fever
7.2.4. Tetanus
7.2.5. Equine Influenza
7.2.6. Equine Herpes Virus
7.2.7. Equine Encephalomyelitis
7.2.8. Others (equine infectious anemia)
7.3. Global Equine Healthcare Market Attractiveness Analysis, by Disease Type
8. Global Equine Healthcare Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.1.1. Key Findings / Developments
8.2. Global Equine Healthcare Market Value Forecast, by Distribution Channel, 2017–2028
8.2.1. Veterinary Hospitals & Clinics
8.2.2. Retail Pharmacies & Drug Stores
8.2.3. Others
9. Global Equine Healthcare Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Equine Healthcare Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. North America Equine Healthcare Market Attractiveness Analysis, by Region
10. North America Equine Healthcare Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028
10.2.1. Drugs
10.2.1.1. Anti-infectives
10.2.1.2. Anti-infectives
10.2.1.3. Anti-inflammatory
10.2.1.4. Parasiticides
10.2.1.5. Others
10.2.1.6. Transfer Lifts
10.2.1.7. Door Openers
10.2.1.8. Others
10.2.2. Vaccines
10.2.2.1. Inactivated
10.2.2.2. Live Attenuated
10.2.2.3. Recombinant
10.2.2.4. Others
10.2.2.5. Others
10.2.3. Medical Supplemental Feed
10.2.3.1. Minerals
10.2.3.2. Vitamins
10.2.3.3. Protein
10.2.3.4. Enzyme
10.2.3.5. Others
10.3. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027
10.3.1. West Nile Virus
10.3.2. Equine Rabies
10.3.3. Potomac Horse Fever
10.3.4. Tetanus
10.3.5. Equine Influenza
10.3.6. Equine Herpes Virus
10.3.7. Equine Encephalomyelitis
10.3.8. Others (equine infectious anemia)
10.4. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
10.4.1. Veterinary Hospitals & Clinics
10.4.2. Retail Pharmacies & Drug Stores
10.4.3. Others
10.5. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Equine Healthcare Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Disease Type
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Equine Healthcare Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028
11.2.1. Drugs
11.2.1.1. Anti-infectives
11.2.1.2. Anti-infectives
11.2.1.3. Anti-inflammatory
11.2.1.4. Parasiticides
11.2.1.5. Others
11.2.1.6. Transfer Lifts
11.2.1.7. Door Openers
11.2.1.8. Others
11.2.2. Vaccines
11.2.2.1. Inactivated
11.2.2.2. Live Attenuated
11.2.2.3. Recombinant
11.2.2.4. Others
11.2.2.5. Others
11.2.3. Medical Supplemental Feed
11.2.3.1. Minerals
11.2.3.2. Vitamins
11.2.3.3. Protein
11.2.3.4. Enzyme
11.2.3.5. Others
11.3. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027
11.3.1. West Nile Virus
11.3.2. Equine Rabies
11.3.3. Potomac Horse Fever
11.3.4. Tetanus
11.3.5. Equine Influenza
11.3.6. Equine Herpes Virus
11.3.7. Equine Encephalomyelitis
11.3.8. Others (Equine Infectious Anemia)
11.4. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
11.4.1. Veterinary Hospitals & Clinics
11.4.2. Retail Pharmacies & Drug Stores
11.4.3. Others
11.5. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Equine Healthcare Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Disease Type
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Asia Pacific Equine Healthcare Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028
12.2.1. Drugs
12.2.1.1. Anti-infectives
12.2.1.2. Anti-infectives
12.2.1.3. Anti-inflammatory
12.2.1.4. Parasiticides
12.2.1.5. Others
12.2.1.6. Transfer Lifts
12.2.1.7. Door Openers
12.2.1.8. Others
12.2.2. Vaccines
12.2.2.1. Inactivated
12.2.2.2. Live Attenuated
12.2.2.3. Recombinant
12.2.2.4. Others
12.2.2.5. Others
12.2.3. Medical Supplemental Feed
12.2.3.1. Minerals
12.2.3.2. Vitamins
12.2.3.3. Protein
12.2.3.4. Enzyme
12.2.3.5. Others
12.3. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027
12.3.1. West Nile Virus
12.3.2. Equine Rabies
12.3.3. Potomac Horse Fever
12.3.4. Tetanus
12.3.5. Equine Influenza
12.3.6. Equine Herpes Virus
12.3.7. Equine Encephalomyelitis
12.3.8. Others (equine infectious anemia)
12.4. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
12.4.1. Veterinary Hospitals & Clinics
12.4.2. Retail Pharmacies & Drug Stores
12.4.3. Others
12.5. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Equine Healthcare Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Disease Type
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Latin America Equine Healthcare Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028
13.2.1. Drugs
13.2.1.1. Anti-infectives
13.2.1.2. Anti-infectives
13.2.1.3. Anti-inflammatory
13.2.1.4. Parasiticides
13.2.1.5. Others
13.2.1.6. Transfer Lifts
13.2.1.7. Door Openers
13.2.1.8. Others
13.2.2. Vaccines
13.2.2.1. Inactivated
13.2.2.2. Live Attenuated
13.2.2.3. Recombinant
13.2.2.4. Others
13.2.2.5. Others
13.2.3. Medical Supplemental Feed
13.2.3.1. Minerals
13.2.3.2. Vitamins
13.2.3.3. Protein
13.2.3.4. Enzyme
13.2.3.5. Others
13.3. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027
13.3.1. West Nile Virus
13.3.2. Equine Rabies
13.3.3. Potomac Horse Fever
13.3.4. Tetanus
13.3.5. Equine Influenza
13.3.6. Equine Herpes Virus
13.3.7. Equine Encephalomyelitis
13.3.8. Others (equine infectious anemia)
13.4. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
13.4.1. Veterinary Hospitals & Clinics
13.4.2. Retail Pharmacies & Drug Stores
13.4.3. Others
13.5. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America Latin America
13.6. Latin America Equine Healthcare Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Disease Type
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region
14. Middle East & Africa Equine Healthcare Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028
14.2.1. Drugs
14.2.1.1. Anti-infectives
14.2.1.2. Anti-infectives
14.2.1.3. Anti-inflammatory
14.2.1.4. Parasiticides
14.2.1.5. Others
14.2.1.6. Transfer Lifts
14.2.1.7. Door Openers
14.2.1.8. Others
14.2.2. Vaccines
14.2.2.1. Inactivated
14.2.2.2. Live Attenuated
14.2.2.3. Recombinant
14.2.2.4. Others
14.2.2.5. Others
14.2.3. Medical Supplemental Feed
14.2.3.1. Minerals
14.2.3.2. Vitamins
14.2.3.3. Protein
14.2.3.4. Enzyme
14.2.3.5. Others
14.3. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027
14.3.1. West Nile Virus
14.3.2. Equine Rabies
14.3.3. Potomac Horse Fever
14.3.4. Tetanus
14.3.5. Equine Influenza
14.3.6. Equine Herpes Virus
14.3.7. Equine Encephalomyelitis
14.3.8. Others (equine infectious anemia)
14.4. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
14.4.1. Veterinary Hospitals & Clinics
14.4.2. Retail Pharmacies & Drug Stores
14.4.3. Others
14.5. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Equine Healthcare Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Disease Type
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share / Position Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Bayer AG (Bayer Animal Healthcare)
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2. Financial Analysis
15.4.1.3. Growth Strategies
15.4.1.4. SWOT Analysis
15.4.2. Boehringer Ingelheim
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2. Financial Analysis
15.4.2.3. Growth Strategies
15.4.2.4. SWOT Analysis
15.4.3. Ceva Santé Animale
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2. Financial Analysis
15.4.3.3. Growth Strategies
15.4.3.4. SWOT Analysis
15.4.4. Eli Lilly and Company (Elanco)
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2. Financial Analysis
15.4.4.3. Growth Strategies
15.4.4.4. SWOT Analysis
15.4.5. Equine Products U.K. Ltd.
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2. Financial Analysis
15.4.5.3. Growth Strategies
15.4.5.4. SWOT Analysis
15.4.6. Merck & Co. (Merck Animal Healthcare)
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2. Financial Analysis
15.4.6.3. Growth Strategies
15.4.6.4. SWOT Analysis
15.4.7. Sanofi (Merial)
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2. Financial Analysis
15.4.7.3. Growth Strategies
15.4.7.4. SWOT Analysis
15.4.8. Purina Animal Nutrition LLC
15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.8.2. Financial Analysis
15.4.8.3. Growth Strategies
15.4.8.4. SWOT Analysis
15.4.9. Vetoquinol S.A.
15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.9.2. Financial Analysis
15.4.9.3. Growth Strategies
15.4.9.4. SWOT Analysis
15.4.10. Zoetis
15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.10.2. Financial Analysis
15.4.10.3. Growth Strategies
15.4.10.4. SWOT Analysis
List of Table
Table 01: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028
Table 02: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028
Table 03: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028
Table 04: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Region, 2021–2028
Table 05: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028
Table 06: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028
Table 07: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028
Table 08: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Country, 2021–2028
Table 09: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028
Table 10: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028
Table 11: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028
Table 12: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2028
Table 13: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028
Table 14: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028
Table 15: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028
Table 16: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2028
Table 17: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028
Table 18: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028
Table 19: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028
Table 20: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2028
Table 21: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028
Table 22: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028
Table 23: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028
Table 24: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2028
List of Figure
Figure 01: Equine Healthcare Market Snapshot
Figure 02: Global Equine Healthcare Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2028
Figure 03: Market Value Share, by Product, 2020
Figure 04: Market Value Share, by Disease Type, 2020
Figure 05: Market Value Share, by Distribution Channel, 2020
Figure 06: Market Value Share, by Region, 2020
Figure 07: Global Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028
Figure 08: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs, 2017–2028
Figure 09: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2017–2028
Figure 10: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medical Supplemental Feed, 2017–2028
Figure 11: Global Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028
Figure 12: Global Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028
Figure 13: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by West Nile Virus, 2017–2028
Figure 14: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by EQUINE RABIES, 2017–2028
Figure 15: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Potomac Horse Fever, 2017–2028
Figure 16: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Tetanus, 2017–2028
Figure 17: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equine Influenza, 2017–2028
Figure 18: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equine Herpes Virus, 2017–2028
Figure 19: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equine Encephalomyelitis, 2017–2028
Figure 20: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others (Equine Infectious Anemia), 2017–2028
Figure 21: Global Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028
Figure 22: Global Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028
Figure 23: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Veterinary Hospitals & Clinics, 2017–2028
Figure 24: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies & Drug Stores, 2017–2028
Figure 25: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2028
Figure 26: Global Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028
Figure 27: Global Equine Healthcare Market Value Share Analysis, by Region, 2020 and 2028
Figure 28: Global Equine Healthcare Market Attractiveness Analysis, by Region, 2021–2028
Figure 29: North America Equine Healthcare Market Size (US$ Mn) Forecast, 2021–2028
Figure 30: North America Equine Healthcare Market Attractiveness Analysis, by Country, 2021–2028
Figure 31: North America Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028
Figure 32: North America Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028
Figure 33: North America Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028
Figure 34: North America Equine Healthcare Market Value Share Analysis, by Country, 2020 and 2028
Figure 35: North America Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028
Figure 36: North America Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028
Figure 37: North America Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028
Figure 38: Europe Equine Healthcare Market Size (US$ Mn) Forecast, 2021–2028
Figure 39: Europe Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021–2028
Figure 40: Europe Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028
Figure 41: Europe Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028
Figure 42: Europe Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028
Figure 43: Europe Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 44: Europe Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028
Figure 45: Europe Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028
Figure 46: Europe Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028
Figure 47: Asia Pacific Equine Healthcare Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017– 2028
Figure 48: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021–2028
Figure 49: Asia Pacific Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028
Figure 50: Asia Pacific Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028
Figure 51: Asia Pacific Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028
Figure 52: Asia Pacific Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 53: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028
Figure 54: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028
Figure 55: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028
Figure 56: Latin America Equine Healthcare Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 57: Latin America Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021–2028
Figure 58: Latin America Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028
Figure 59: Latin America Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028
Figure 60: Latin America Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028
Figure 61: Latin America Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 62: Latin America Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028
Figure 63: Latin America Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028
Figure 64: Latin America Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028
Figure 65: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, 2017–2028
Figure 66: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021–2028
Figure 67: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028
Figure 68: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028
Figure 69: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028
Figure 70: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 71: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028
Figure 72: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028
Figure 73: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028
Figure 74: Global Equine Healthcare Market Share Analysis, by Company, 2020
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Equine Healthcare Market
